BIOLOGICALLY ACTIVE OXADIAZOLE by Shukla, Chhama & Srivastava, Sanchit
Chhama et al                                          Journal of Drug Delivery & Therapeutics. 2015; 5(6):8-13 8 
© 2011-15, JDDT. All Rights Reserved                                                   ISSN: 2250-1177                                             CODEN (USA): JDDTAO 
Available online on 15.11.2015 at http://jddtonline.info 
Journal of Drug Delivery and Therapeutics 
Open access to Pharmaceutical and Medical research 
© 2015, publisher and licensee JDDT, This is an Open Access article which permits unrestricted noncommercial use, provided the original 
work is properly cited 
 
REVIEW ARTICLE 
BIOLOGICALLY ACTIVE OXADIAZOLE 
Chhama Shukla*, Sanchit Srivastav 
Noida Institute of Engineering and Technology, Gr. Noida (UP), India-201308 
*Corresponding Author’s Email: chhama.shukla92@gmail.com, Contact: +918287661765 
Received 25 Sep 2015; Review Completed 17 Oct 2015; Accepted 17 Oct 2015, Available online 15 Nov 2015 
 
 
 
 
 
 
 
 
 
 
 
 
 
1. NTRODUCTION: 
Oxadiazole is a heterocyclic aromatic compound having 
molecular formula C2H2N2O. It is a five membered 
ring consisting of 2 nitrogen atoms, 2 carbon atoms,1 
oxygen atom and 2 double bonds
1
. It is derived from 
furan by replacing two -CH= group with 2 pyridine 
typed nitrogen (-N=).  So possibly there are 4 isomers 
of oxadiazole which depends on the nitrogen atom 
position in the ring as follows:    
                                                                                                                      
  
 
Figure 1.0 
 
1,2,4- Oxadiazole, 1,2,5-oxadiazole, and 1,3,4-
oxadiazole are known, but the 1,2,3-isomer is unstable 
and reverts to the diazoketone tautomer.
2 
1, 3, 4-
Oxadiazole derivatives shows a wide range of 
biological activities including antibacterial, 
antitubercular, vasodialatory, antifungal, cytotoxic, anti-
inflammatory, analgesic, hypolipidemic, anticancer and 
ulcerogenic activities.
3 
 
1.1 Physical properties of oxadiazole: In 1955 the first 
monosubstituted 1,3,4-oxadiazoles were reported by 
two independent laboratories 
4,5
. Nature of 1,3,4 
oxadiazoles is liquid. They have a boiling point of 150º 
C 
6-8
. It does not have any freely rotating bonds. It has 3 
hydrogen bond acceptors. Derivatives of 1,3,4 
oxadiazoles like 2,5-disubstituted -1,3,4-oxadiazoles are 
found to be colorless. 
 
 
ABSTRACT 
As we know that, Oxadiazole is a heterocyclic compound containing an oxygen atom and two nitrogen atoms in a five-
membered ring and is derived from furan by substitution of two methylene groups (=CH) with two pyridine type nitrogen (-N=) 
[1,2]. There are three known isomers that is 1,2,4-oxadiazole, 1,2,3-oxadiazole and 1,2,5-oxadiazole (Figure 1.0). However, 
1,3,4-oxadiazole and 1,2,4-oxadiazole are better known, and more widely studied by researchers because of their many 
important chemical and biological properties. Among heterocyclic compounds, 1,3,4-oxadiazole has become an important 
construction motif for the development of new drugs. Compounds containing 1,3,4-oxadiazole cores have a broad biological 
activity spectrum including antibacterial, antifungal, analgesic, anti-inflammatory, antiviral, anticancer, antihypertensive, 
anticonvulsant, and anti-diabetic properties. They have also attracted interest in medicinal chemistry as surrogates (bioisosteres) 
for carboxylic acids, esters and carboxamides. The ability of 1,3,4-oxadiazole heterocyclic compounds to undergo various 
chemical reactions has made them important for molecule planning because of their privileged structure, which has enormous 
biological potential. Some examples of compounds containing the 1,3,4-oxadiazole unit currently used in clinical medicine are: 
Raltegravir as an antiretroviral drug and Zibotentan as an anticancer agent. They possesses various other biological activities 
and having various synthetic approaches, some of them are presented here in the aritcle. 
Keywords: Oxadiazoles synthetic approaches, biologically active ozadiazoles, oxadiazoles as anticancers etc. 
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Figure 2.0 
 
The IR spectra of 1,3,4-oxadiazole is characterized by 
bonds present at1640-1650 cm (C=N) and at 1020cm 
(C=O) 
9
. The position of both protons in H-NMR is 
1.27.The refractive index n D of 1,3,4- oxadiazole is 1.43 
10
. According to the mass spectra the base peak is the 
molecular ion peak. The solubility of oxadiazole in water 
varies with the substituent present: 2,5-dimethyl-1,3,4- 
oxadiazole is miscible with water in all proportions 
whereas the solubility of 2,5-diphenyl-1,3,4- oxadiazole 
in water is less 
11
.  
1.2 Chemistry of oxadiazole 
Oxadiazole shows inductive effect because of the 
presence of heteroatom in the ring and thus it is 
considered to be a weak base. It consists of 2 pyridine 
like nitrogen, due to which it exhibits conjugate diene 
type character. Electrophillic substitution at carbon is 
very difficult in this case due to less electron density 
which is mainly due to the presence of pyridine like 
nitrogen in the ring that shows electron withdrawal 
effect.  
Due to the presence of two pyridine type nitrogen, the 
aromaticity will be removed. Many studies on 
comparison between 1,2,4- and 1,3,4-oxadiazole pairs 
shows that, in all cases,1,3,4-oxadiazole isomer shows 
lower magnitude lipophilicity as compared to its isomeric 
partner. Other differences involve metabolic stability, 
hERG inhibition, and aqueous solubility. All these 
studies favoured the 1, 3, 4-oxadiazole isomers. The 
difference in profile between the 1, 2, 4 and 1, 3, 4 
regioisomers can be rationalized by their intrinsically 
different charge distributions. The 1, 3, 4-oxadiazole 
undergoes number of reactions including electrophillic 
substitution, nucleophilic substitution, thermal and 
photochemical.  
1.2.1 Electrophillic reaction 
Low electron density of carbon atom in 1,3,4-oxadiazole, 
owing to the electron withdrawal by pyridine type 
nitrogen atom and also because of protonation possibility 
at nitrogen atom, the electrophilic substitution reactions 
are very difficult in oxadiazoles. Association with 
electron releasing groups in the ring can lead to 
electrophilic attack at nitrogen. No examples of nitration 
and sulphonation are yet found though research is being 
carried out.  
 
Figure 3.0 
1.2.2 Nucleophillic reaction 
Oxadiazoles normally are resistant to nucleophilic 
substitution reactions except for halogen- substituted 
oxadiazoles. In this reaction nucleophile will replace 
halogen atom. Due to electron density at C2and C5 many 
nucleophilic reagents can cause ring cleavage reactions. 
 
Figure 4.0 
1.2.3 Thermal and Photochemical Reactions  
Oxadiazoles, specifically 1, 3,4oxadiazoles are thermally 
stable. On substitution by aryl and perfluroalkyl groups 
the thermal stability of oxadiazole increases. When 
heated at high temperature (210 - 230°C) 
oxadiazolinones get decarboxylated to form nitrilimines, 
which when recycled forms 2-alkoxy-1, 3,4oxadiazoles 
2
.  
 
Figure 5.0 
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2. SYNTHETIC APPROACHES OF OXADIAZOLE  
2.1. Scheme 1 
From Thiosemicarbazide  
Barbuceanu et. al.; (2010); reported the synthesis of 
oxadiazole by reacting N1-[4-(4- bromophenylsulfonyl) 
benzoyl]-N4-(4-flourophenyl)-thiosemicarbazide
12
 with 
(a) Mercuric Oxide (HgO) in ethanol media (b) I2/KI in 
NaOH solution media. 
 
 
Scheme 1 
 
2.2 Scheme 2 
From Isothiazole  
Kiselyov et. al.; (2010); reported the synthesis of 
oxadiazole by refluxing isothiazole derivative with neat 
hydrazine hydrate for 4 hrs. The hydrazide so obtained 
can be further reacted with isothiocynates followed by 
in situ cyclization of the intermediate 
thiosemicarbazides with DCC to afford the key 
molecules 
13
.  
 
 
Scheme 2 
 
2.3 Scheme 3 
From N-acyl hydrazones  
Prakash et. al.; (2010); reported the synthesis of a series 
of novel 2,5-disubstituted 1,3,4- oxadiazoles, by 
oxidative cyclization of pyrazolylaldehyde N-acyl 
hydrazones promoted by iodobenzene diacetate under 
mild conditions
 14.  
 
Scheme 3 
2.4 Scheme 4 
From Chalcones  
Kamble et. al.; (2010); reported the microwave assisted 
synthesis of 1, 3, 4-oxadiazole from Chalcones. This 
microwave assisted synthesis lead to the cleaner reactions 
as well as afforded high yields and shorter reaction times. 
The chalcones underwent a rapid cyclisation with 
hydrazine hydrate using Polyethylene glycol (PEG 200) 
and formic acid as solvents. The Compound 2 on 
bromination and heating with acetic anhydride afforded 
the Oxadiazole derivatives (compound 3)
15
. 
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Scheme 4 
 
2.5 Scheme 5  
From acid hydrazides  
The formation of 1,3,4 –oxadiazole via condensation of 
various alkyl hydrazides with substituted acids using 
various cyclodehydrogenating agents are reported in 
literature. A few of them are mentioned below. Husain et. 
al.; (2010); reported the synthesis of 1,3,4-Oxadiazole by 
reacting 4-oxo- 4(biphenyl-4-yl)butanoic acid (fenbufen) 
with aryl acid hydrazides in phosphorous oxychloride 
16
. 
 
 
Scheme 5 
 
2.6 Scheme 6 
From acetic acid hydrazide  
Kumar et. al.; (2010); reported the synthesis of 5-
[(biphenyl-4-yloxy)-methyl]-2-substituted- 1,3,4-
oxadiazoles [Figure 8] by treatment of 2-(biphenyl-4-
yloxy) acetic acid hydrazide with appropriate aromatic 
acid in presence of phosphorous oxychloride 
17
. 
 
Scheme 6 
3. BIOLOGICAL APPROACHES OF 
OXADIAZOLE 
3.1 Calcium Channel Blocker  
Girish R. BankaraIn investigated whether the correction 
of endothelial dysfunction is dependent on the 
normalization of high blood pressure levels by 1,3,4-
oxadiazole derivative (NOX-1) in deoxycorticosterone 
acetate (DOCA-salt) and NG-nitro-l-arginine (L-NNA) 
hypertensive rats. In DOCA-salt and L-NNA 
hypertensive rats, the mean systolic blood pressure 
(MSBB) was 185.3±4.7 and 170.2±4.1mmHg, whereas 
after administration of NOX-1 to hypertensive rats, 
MSBB was 127.8±4.5 and 120.2±5.1mmHg, respectively 
18
. 
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Figure 6.0 
3.2 Anti-Osteoporotic Activity  
Usman Ghani et al have prepared a series of cathepsin K 
inhibitors bearing the keto-1,3,4-oxadiazole warhead 
capable of forming a hemithioketal complex with the 
target enzyme. By modifying binding moieties at the P1, 
P2, and prime side positions of the inhibitors, selectivity 
over cathepsins B, L, and S are achieved and also sub-
nanomolar potency against cathepsin K. This series thus 
represents a promising chemotype that could be used in 
diseases implicated by imbalances in cathepsin K activity 
such as osteoporosis 
19
. 
 
Figure 7.0 
3.3 Antiviral Activity  
The unsubstituted aromatic sulfonamides of type 
ArSO2NH2 act as strong  carbonic anhydrase inhibitors 
and potency of such compounds is drastically increased 
by N- substitution of the sulphonamide moiety. Iqbal et 
al. studied the antiviral activity of novel benzene 
sulfonamides bearing 2,5- disubstituted-1,3,4-oxadiazole 
moiety
7
 by screening them against human 
immunodeficiency virus type 1(HIV-1) using the XTT 
assay in MT-4 cells. The antiviral activity of synthesized 
compounds was evaluated at concentrations of 5, 25 and 
50μg/ml. The results showed that one compound was 
found to be the most active amongst the tested 
compounds; it produced 14%, 21% and 42% reduction of 
viral replication at concentrations of 5, 25 and 50μg/ml 
respectively comparable to that of standard antiviral drug 
20
 
  
Figure 8.0 
3.4 Anticancer activity 
Formagio et al. studied some novel 2- substituted-1,3,4-
oxadiazole-5-yl bearing β-carboline derivatives (13) for 
their antitumour activity and evaluated by in- vitro 
process. Some compounds showed high selectivity and 
potent anticancer activity against human tumor lines 
melanoma, breast, lung, leukemia, ovarian, prostate, 
colon and renal. Assays were performed in a 96-well 
plate using four concentrations at 10-fold dilutions (0.25 
mg/ml to 250 mg/ml) for each test compound. Two 
compounds showed significant anticancer activity on 
comparison with standard anticancer drug 
21
.  
 
Figure 9.0 
3.5 Anti inflammtory activity 
Asif Husain et al reported the synthesis of novel series of 
2-[3-(4-bromophenyl)propan-3- one]-5- (substituted 
phenyl)-1,3,4-oxadiazoles from 3-(4-bromobenzoyl) 
propionic acid with the aim to get better anti-
inflammatory and analgesic agents with minimum or 
without side effects (ulcerogenicity). Two compounds, 2-
[3-(4- bromophenyl)- propan-3-one]-5-(4-chlorophenyl)- 
1,3,4-oxadiazole and 2- [3-(4-bromophenyl)propan-3- 
one]-5-(3,4-dimethoxy phenyl)-1,3,4-oxadiazole with 
anti-inflammatory activity of 59.5 and 61.9 %, 
respectively, were found to have comparable activity 
with that of indomethacin which showed 64.3 % activity 
at the same dose of 20 mg/kg 
22
.  
 
  Figure 10.0 
3.6 Anti microbial activity 
Mishra et. al.; (2010); synthesised a series of Oxadiazole 
(Compound 8) and then final compounds were tested for 
their antimicrobial activity by cup and plate method. 
Among the tested compound 8a showed promising 
antibacterial activity against Gram +ve bacteria i.e. 
Streptococcus pneumonia and compound 8b showed 
promising antibacterial activity against Gram –ve 
bacteria i.e. Escherichia coli as compared to standard 
drugs Ofloxacin and Levofloxacin 
23
.   
 
Where 8a:  R = 4-OCH3C6H5 
8b: R = 4-N02C6H5 
Figure 11.0 
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